Product Information
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.6695 per EA under NDC 42858060203. Its NADAC has been published 256 times since Aug 4, 2021.
Strength
8; 2 mg/1; mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858060203
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205601On Market Since
4/13/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has been published 256 times since Aug 4, 2021, and over the history we have for it it has declined 43.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6695 per EA |
|---|---|
| All-time high | $1.1932 (Aug 11, 2021) |
| All-time low | $0.6450 (Nov 20, 2024) |
| 52-week high | $0.7397 |
| 52-week low | $0.6616 |
| Median price | $0.9359 |
| Average price | $0.8911 |
| Largest weekly change | +29.6% (Aug 21, 2024) |
| Weeks tracked | 256 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.6695 per EA (NDC 42858060203), effective Jun 24, 2026.
How has the price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has declined 43.9%. It has been tracked across 256 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
Since Aug 4, 2021, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has ranged from a low of $0.6450 (Nov 20, 2024) to a high of $1.1932 (Aug 11, 2021), with a median of $0.9359 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, but none are currently priced below it.
Who manufactures BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET (NDC 42858060203) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification